Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU | SpringerLink
Puma Biotechnology
JP Morgan Healthcare, Day 3: Puma Biotechnology, Natera | Precision Oncology News
Puma Biotechnology: Who Are They? What Happened? And, Where Are They Going? (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer Symposium | Business Wire
Neratinib maleate (HKI-272 maleate) | HER2/EGFR Inhibitor | MedChemExpress
HER2+ Breast Cancer Patients' Access to Neratinib Expanded Through Puma's EAP
PUMA NER 10-005 – SOLTI
Puma Biotechnology out-licenses Nerlynx in Canada
Puma Biotechnology Files NDS For NERLYNX In Canada
Neratinib (Hertinib 40mg) Rx - Medicine For World (MFW)
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Neratinib - wikidoc
A New Drug on the Horizon for HER2 Breast Cancer Patients | Avise Analytics
Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer Symposium | Business Wire
Sociedad Ecuatoriana de Oncología - 🤓 La FDA aprobó a neratinib (Puma Biotechnology) en combinación con capecitabina para el tratamiento del cáncer de mama HER2 + avanzado o metastásico en pacientes que
Puma Biotechnology
Puma Biotechnology reports interim SUMMIT results for neratinib | Drug Discovery News
KEGG DRUG: Neratinib maleate
Cancer hopeful neratinib plagued by diarrhea, analysis shows, but Puma cites a solution | Fierce Pharma
Puma Biotechnology's Neratinib Set To Target Extended Adjuvant Opportunity (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT 'Basket' Trial of Neratinib at the ASCO 2022 Annual Meeting
Nerlynx (neratinib) FDA Approval History - Drugs.com
Puma Biotechnology
